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Abstract 
Background and purpose. We aimed to compare single incision laparoscopic cholecystectomy 
(SILC) to the standard multiport technique (MLC) for clinically relevant outcomes in adults. 
Methods. Systematic review and random-effects meta-analysis of randomized trials. Results. 
We identified 30 trials (SILC N=1209, MLC N=1202) mostly of moderate-to-low quality. 
Operating time (30 trials): longer with SILC (WMD=12.4 min, 95%CI 9.3, 15.5; p<0.001), but 
difference reduced with experience – in 10 large trials (1321 patients) WMD=5.9 (-1.3, 13.1; 
p=0.105). Intra-operative blood loss (12 trials, 1201 patients): greater with SILC, but difference 
practically irrelevant (WMD=1.29 mL, 0.24-2.35; p=0.017). Procedure failure (27 trials, 2277 
patients): more common with SILC (OR=13.9, 4.34-44.7; p<0.001), but overall infrequent (SILC 
pooled incidence 4.39%) and almost exclusively addition of a trocar. Post-operative pain (29 
trials) and hospital stay (22 trials): no difference. Complications (30 trials): infrequent (SILC 
pooled incidence 5.35%) with no overall SILC vs. MLC difference. Incisional hernia (19 trials, 
1676 patients): very rare (15 vs. 4 cases), but odds significantly higher with SILC (OR=4.94, 1.26-
19.4; p=0.025). Cosmetic satisfaction (16 trials, 11 with data at 1-3 months): in 5 trials with non-
blinded patients (N=513) in favor of SILC (SMD=1.83, 0.13, 3.52; p=0.037), but in 6 trials with 
blinded patients (N=719) difference small and insignificant (SMD=0.42, -1.12, 1.96; p=0.548). 
Discussion. SILC outcomes largely depend on skill, but irrespectively of it, compared to MLC, it 
requires somewhat longer operating time, risk of incisional hernia is higher (but overall very 
low) and early cosmetic benefit is modest. Conclusion. From the (in)convenience and safety 
standpoint, SILC is an acceptable alternative to MLC with a modest cosmetic benefit. 
 
3 
 
Introduction 
Laparoscopic cholecystectomy is a widely accepted standard in treatment of benign gallbladder 
diseases.1 Shortly after Mühe2 had performed the first laparoscopic cholecystectomy in 1985 
using a modified laparoscope, Mouret3 performed the first video-assisted laparoscopic 
cholecystectomy in 1987. The procedure gained wide acceptance due to advantages of a smaller 
incision, less postoperative pain, shorter hospital stay and faster return to everyday living as 
compared to the traditional open approach.4 To further enhance these benefits, even more 
minimally invasive techniques have been developed. These include needlescopic 
cholecystectomy, natural orifice transluminal endoscopic surgery (NOTES) cholecystectomy and 
single-incision laparoscopic cholecystectomy (SILC). The latter technique was first described in 
19955. Although it might not have enjoyed a widespread use, it has gained a fair share of 
popularity: we were able to identify 16 meta-analyses of randomized controlled trials (RCTs) 
comparing SILC to the standard multiport laparoscopic cholecystectomy (MLC) published by the 
mid 2013 (Table 1). The two largest reviews referred to 1613 and 249 RCTs in adults (Table 1). 
Since further RCTs have been conducted in the meantime, we found it plausible to perform an 
up-dated literature search and a systematic review of RCTs comparing SILC to MLC. 
 
Materials and Methods 
This study followed methodological recommendations for systematic reviews as given in the 
PRIMSA statement22 and Cochrane Handbook for Systematic Reviews.23 
Literature search  
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Electronic databases [Pubmed MEDLINE, Ovid MEDLINE, EBM Reviews (all Cochrane Library), 
Scopus – Health Sciences, ISI Web of Knowledge, EBSCO (Academic Search Complete, CINAHL 
and ERIC) and Google Scholar] were searched till December 9, 2013. The strategy was designed 
to be sensitive, not specific: the search terms “laparoscopic“, “cholecystectomy“, “single port“, 
“single site“, “single incision“, “transumbilical“, “laparo-endoscopic“, “SILS“ and “SILC“ were 
used in combination with Boolean operators AND and OR (“all fields”). No limits, filters or 
restrictions were set. Reference lists of identified reviews/articles were also searched (Fig. 1). 
Study selection and abstracting 
Study inclusion criteria were: a) RCT, irrespective of language, country of origin, blinding or 
publication status; b) compared SILC to MLC for a benign gallbladder disease. We defined SILC 
as a laparoscopic cholecystectomy through a single skin incision either using multiport devices 
specifically designed for SILC or using conventional trocars introduced through separate fascial 
incisions. MLC was defined as a laparoscopic cholecystectomy through three or four skin 
incisions irrespective of their length and position; c) included adults ≥18 years of age; d) did not 
report duplicate data; e) provided data on at least one of the pre-defined outcomes. Exclusion 
of duplicate publications was computer-assisted (Reference Manager version 12, Thomson 
Reuters) (Fig 1). Study selection/abstracting were performed by two independent authors. 
Discrepancies were resolved through a consensus of all authors. 
Study quality assessment 
Two authors independently evaluated study quality using the Cochrane Collaboration 
recommended tool23 that critically assesses selection, performance, detection, attrition, 
reporting and other potential biases. It categorizes risks (of bias) as “low” (explicit evidence of 
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measures to minimize the bias), “high” (explicit evidence of no measures to control the bias) 
and “uncertain”. In the category of “other biases” we assessed the risk of differential expertise 
bias, i.e., a bias due to discrepancy in investigators’ (in)experience with SILC relative to MLC. 
Different views have been expressed about the SILC learning curve – 524, 1025 or 20 to 2526 
surgeries have been suggested as needed to reach the plateau. We chose the learning curve of 
10 cases as a cut-off: when there was explicit evidence that before the trial investigators had 
performed <10 SILC procedures, the risk was assessed as “high”; when at least 10 procedures 
had been performed, the risk was assessed as “low”; otherwise the risk was assessed as 
“uncertain”. Disagreements were resolved through a consensus of all authors. 
Outcomes for quantitative review 
We defined seven (co)primary outcomes of interest in order to comprehensively characterize 
SILC in relation to MLC: a) Intra-operative - duration of surgery; blood loss; procedure failure. 
For SILC, failure was defined as addition of an extra port (standard or needlescopic) or as 
conversion to open surgery or MLC (transabdominal sutures or wires for gallbladder retraction 
were acceptable). For MLC, failure was defined as addition of an extra port or conversion to 
open surgery or SILC; b) Peri- and postoperative - spontaneous abdominal pain at rest 
(quantitative data on pain perception); complications (biliary, wound-related and other 
complications excluding nausea/vomiting and non-specific mild adverse events); length of 
hospital stay; patient satisfaction with the cosmetic outcome. 
Data extraction 
Data were extracted independently by two authors and discrepancies were resolved through a 
consensus of all authors. A digitizing software Dagra (Blue Leaf Software, New Zealand) was 
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used to retrieve numerical values from graphs. For dichotomous outcomes, patient-level data 
(n/N) were extracted. A non-event was considered reported only when explicitly stated, 
otherwise a particular outcome was considered not reported. Validated methods were used to 
estimate means and standard deviations (SDs) from medians and ranges27 or to input SDs28 
where needed. Most of the cosmetic scales assigned higher values to better outcomes hence 
inverse values were used in the case of scales with the opposite scoring systems.  
Effect measures 
Continuous outcomes quantified by different scales (cosmetic satisfaction, pain) were pooled as 
standardized mean difference (SMD), otherwise (weighted) mean difference (WMD) was used. 
For cosmesis, 15 different time points (day 3 to 1 year after surgery) were reported across the 
trials. They were collapsed into four postoperative periods: 1-21 days, 1-3 months, 6 months 
and 1 year post-surgery. For pain, 16 different time points (2 hours to 1 month after surgery) 
were reported. They were collapsed to 11 periods: up to 3 hours, 4 hours, 6-8 hours, 12 hours, 
24 hours, 48 hours, 72 hours, 4-5 days, 7 days, 10-14 days and 1 month post-surgery. Time 
points not fitting into these periods and/or with data from <3 trials were omitted. When 
multiple time-point data within a period were reported, pooled mean and SD represented the 
respective time period. Dichotomous outcomes were summarized as odds ratios (OR). 
Data analysis 
Random-effects meta-analysis was employed. For repeated-measures outcomes, separate 
estimates for different time periods (no pooling) were produced. Heterogeneity was evaluated 
by the Q-test and I2, and publication bias was assessed by inspection of the funnel plots, Egger’s 
regression and trim-and-fill method. Conventional meta-analytical methods do not perform well 
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with sparse binary data (procedure failure, complications).23,29,30 For convenience, they were 
summarized as Mantel-Haenszel (M-H) odds ratio (OR). However, zero frequency cell correction 
and omission of zero-event studies (inherent to the M-H method) can introduce bias. 23,29,30 
Hence, we implemented methods that use all trials and do not employ corrections: a) a random-
effects method for sparse dichotomous data by Shuster et al.29 and b) random-effects analysis 
within the bivariate binomial-normal model (BN).30 The latter provides estimates of event 
incidence for each treatment and of treatment difference (OR). Between-trial heterogeneity is 
indicated by: (i) across-trial variance (2) of log(odds) by treatment; (ii) covariance between 
log(odds) for two treatments and (iii) across-trial variance of overall treatment effect 
[log(OR)].30 We considered that the effect of surgical skill (SILC) on the SILC vs. MLC differences 
should be investigated. We assumed that trials with more SILC-treated patients came from 
more experienced investigators – a larger patient turn-over would result in more experience 
and possibility to enroll more patients, and a larger trial per se increases experience with the 
procedure (learning through the trial). Therefore, we evaluated the relationship between the 
number of SILC-treated patients and size of the effect. Other predefined factors in exploration 
of heterogeneity were: a) risk of differential expertise bias (pre-trial experience with SILC); b) 
other biases [e.g., risk of performance bias (blinding of participants) in the case of subjective 
outcomes (cosmesis, pain)]. Covariate effects were assessed by random-effects meta-regression 
with residual (restricted) maximum likelihood (REML) estimation. Explanation of heterogeneity 
is illustrated by reduction in 2 and by residual I2.31,32 We used CMA version 2.2 software (Biostat 
Inc., Englewood NJ, USA) and SAS 9.3 for Windows (SAS Inc., Cary, NC, USA) proc nlmixed (BN 
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method)30, proc mixed (meta-regression)33 and a SAS macro for sparse dichotomous data by 
Shuster29 (available from http://ags.bwh.harvard.edu/). 
 
Results 
Characteristics and quality of the included trials 
We identified 30 RCTs (Fig. 1) with 2411 patients (1209 SILC, 1202 MLC). Most trials (25/30) 
included ≤50 SILC-treated patients, follow-up varied considerably across the trials, whereas 
variations of patient demographics across treatments and trials were moderate (Table 2). Trials 
differed regarding the SILC technique and instruments (Table 3). One trial43 included 2 MLC 
groups: 3-port and 4-port. Data were pooled into one MLC group for the following reasons: a) 
only 3 other trials used exclusively a 3-port MLC and two trials combined the 3-port and 4- port 
approaches not making a distinction. Therefore, there was too few data to compare SILC 
separately to a 3-port and a 4-port MLC; b) the results for the two MLC approaches in this one 
trial43 were practically identical. Trials also varied regarding the gallbladder retraction methods 
in SILC, inclusion/exclusion criteria and analgesic strategies (not shown), and blinding (Table 4). 
In 11/30 trials, investigators had performed <10 SILC procedures before the trial, i.e, the risk of 
differential expertise bias was high and it was uncertain in further nine trials (Table 4). Other 
quality limitations were related mainly to the risk of attrition (high in 6/30, uncertain in 8/30 
trials) and performance bias (high in 2/30, uncertain in 19/30 trials) (Table 4). Study quality and 
size did not appear related (Table 5). 
SILC vs. MLC: Intra-operative outcomes 
Operating time 
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Operating time (all trials) was longer with SILC by 12.4 minutes (p<0.001) with high 
heterogeneity (Fig. 2A). Heterogeneity was largely resolved in a meta-regression analysis 
accounting for differential expertise bias (pre-trial SILC experience) and the number of SILC-
treated patients [21.3% heterogeneity explained, I2 reduced from 87% (high) to 47.8% 
(moderate)] (Figure 2B). The SILC vs. MLC WMD in operating time was significantly lower in 
trials with a low risk of bias than in trials with a high risk ( WMD= -11.5 min, p=0.040) (Fig. 2B). 
Similarly, the SILC vs. MLC WMD was significantly lower in trials with >40 SILC-treated patients 
than in other trials ( WMD= -12.0 min, p=0.010) (Fig. 2B). 
Intra-operative blood loss 
Data from 12 trials (1201 patients) indicated a slightly greater (WMD=1.29 mL, p=0.017) blood 
loss with SILC, with negligible heterogeneity (Fig. 3). The SILC vs. MLC difference was consistent 
across the subsets of trials regarding the risk of expertise bias or number of SILC-treated 
patients (not shown). The “one-trial-omitted” analysis indicated consistent treatment difference 
except in the case of removal of studies Cao 201139 or Lai 201144, when difference was reduced 
to ≤1.0 mL and was not statistically significant (not shown). 
Procedure failure 
Data were available from 27 trials (2277 patients), however 5 trials were with no events (26/54 
treatment arms with no events), hence conventional meta-analysis used 22 trials and indicated 
higher odds of procedure failure with SILC vs. MLC with no heterogeneity (Figure 4A). The 
sparse data-specific methods (all 27 trials, no continuity correction) yielded much higher 
estimates of treatment difference (ORs around 8-13) (Fig. 4B). Overall, procedure failure was 
reported for 69/1142 SILC-treated patients (Fig. 4B), where 55 cases referred to addition of a 
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trocar, 2 to conversion to open surgery and 12 to conversion to MLC; whereas MLC failed in 
6/1135 patients [1 addition of a trocar, 2 conversion to open surgery, 1 conversion to SILC38 
(due to the intra-abdominal condition) and 1 conversion from a 3-port to a 4-port procedure]. 
The BN method indicated a random-effects pooled incidence of failure with SILC of 4.39% with 
high heterogeneity (2 =1.43, p=0.019) vs. 0.53% with MLC (no heterogeneity) (Fig. 4B). The SILC 
vs. MLC difference was consistent across the subsets of trials based on the risk of expertise bias 
and the number of SILC procedures (not shown), however experience with SILC apparently 
reduced the risk of procedure failure: in 17 trials with a high/uncertain risk of expertise bias 
estimated incidence of failure was 5.16% with high heterogeneity (2=1.82), whereas in 10 trials 
with a low risk of bias it was 3.60% with no heterogeneity. Similarly, in 17 trials with up to 40 
SILC procedures, estimated incidence of failure was 4.85% with high heterogeneity (2= 1.73), 
whereas in 10 trials with >40 SILCs it was 3.30% and with lower heterogeneity (2 =0.89). 
SILC vs. MLC: Peri- and postoperative outcomes 
Post-operative pain 
Overall, 29 trials reported on post-operative pain but the number of trials/patients across the 
analyzed time periods varied being the largest at 24 hours after the surgery (Fig. 5A). No SILC vs. 
MLC difference was statistically significant although point-estimates were mostly mildly in favor 
of SILC, all with high heterogeneity (Fig. 5A). At 24 hours post-surgery the difference tended 
towards statistical significance (SMD -0.30, p=0.093) (Fig. 5B). Around 1/3 of the between-trial 
variance at 24 hours post-surgery was explained by accounting for the risk of performance bias 
(patients blinded or not) and the number of SILCs in the trial. In 8 trials with a low risk of bias 
(blinded patients), SILC vs. MLC SMD was small and insignificant (SMD -0.15, p=0.591), whereas 
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in other trials it was large and statistically significant (SMD=-0.64, p=0.003) (Fig. 5C). The SILC vs. 
MLC SMD became more negative (more in favor of SILC) with a larger number of SILCs in a trial, 
but only in trials with a high/uncertain risk of performance bias (Fig. 5C). 
Complications 
Data were available from all trials. Cumulative numbers of patients by individual reported 
complications are listed in Table 6. There were no events in 5 trials (16/60 treatment arms with 
no events), hence conventional meta-analysis used 25 trials indicating no difference between 
treatments and no heterogeneity (Fig. 6A). The sparse data-specific methods using all 30 trials 
indicated similarly small treatment effects, but with high between-trial heterogeneity (the BN 
method) (Fig. 6B). The estimated random-effects incidence of complications for SILC (103/1209) 
was 5.35% vs. 3.79% for MLC, both with high variance across trials (Fig. 6B). Treatment 
differences and incidence of complications with SILC were similar in trials with a smaller and a 
larger number of SILC-treated patients (not shown). In 10 trials with a low risk of expertise bias, 
SILC vs. MLC difference was the largest (OR=1.56, 95%CI 0.91-2.67, p=0.096) and the pooled 
incidence in the SILC arm was high (10.7%), whereas in 20 trials with a high/uncertain risk of 
expertise bias there was practically no SILC vs. MLC difference (OR=1.04, p=0.859) and incidence 
in the SILC arms was low (4.0%). Occurrence of incisional hernia was explicitly stated in 19 trials 
(1676 patients), but 12 were with no events (Table 7). Hence, conventional meta-analysis used 
only 7 trials indicating no difference between treatments (Table 7). The sparse data-specific 
methods, however, and particularly the preferred unweighted method by Shuster29 clearly 
indicated a higher risk of incisional hernia with SILC (OR=4.94, p=0.025) (Table 7). 
Hospital stay 
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Data from 22 trials (1864 patients) indicated no difference between the procedures and high 
heterogeneity (Fig. 7). The best explanation of heterogeneity was achieved in a meta-regression model 
accounting for attrition and detection (investigators blinded or not) bias: it explained 33.8% of the 
between-trial variance and the residual I2 was 79.1%. In trials with blinded investigators, i.e., low risk of 
detection bias (12 trials, 536 patients SILC, 566 patients MLC), hospital stay was somewhat shorter with 
SILC and in trials with uncertain risk of bias (10 trials, 374 patients SILC, 388 MLC), it was somewhat 
longer: the difference between the two subsets (-0.28, 95% CI -0.57, 0.01; p=0.061) indicated a greater 
difference in favor of SILC when assessors were blinded. 
Patient satisfaction with the cosmetic outcome 
Overall, 16 trials reported cosmetic outcomes but the number of trials/patients at the analyzed 
time periods varied being the highest at 1-3 months post-surgery (Fig. 8A). All SILC vs. MLC 
differences (SMD) were statistically significantly in favor of SILC and all with high heterogeneity. 
Treatment difference apparently decreased at later time periods (6 months, 1 year post-
surgery) (Fig. 8A). At 1-3 months post-surgery, the difference in favor of SILC was the largest 
(SMD=0.99, p<0.001) (Fig. 8B). Although the effect appeared particularly large in one trial (Pan 
2013)54, the “one-trial-omitted” analysis showed consistently significant difference in favor of 
SILC and consistently high heterogeneity. Heterogeneity at this time point was practically 
completely resolved by accounting for the risk of performance bias [I2 reduced from 94.0% 
(high) to 35.0% (mild)] (Fig. 8C) – in trials with blinded patients (low risk of bias) the difference 
was small and insignificant (SMD=0.42, p=0.548), whereas in other trials it was large and 
significant (SMD=1.83, p=0.037) (Fig. 8C). 
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Discussion 
Using MLC as an example, Allori et al.65 emphasized the need for thorough appraisal of surgical 
innovations before they are accepted as safe and effective. We therefore reasoned that an 
updated evaluation of SILC based on trials comparing it to MLC would be a worthwhile effort. 
Strengths and limitations of the present analysis 
We find the following to be the strengths of the present analysis: a) identification of the largest 
number of RCTs in adults as compared to previous systematic reviews; b) comprehensive 
evaluation of the publication bias; c) systematic evaluation of trial quality; d) use of methods 
designed for sparse dichotomous data and investigation of heterogeneity. However, limitations 
inherent to any systematic review remain: a) existence of unpublished data cannot be excluded; 
b) all review and meta-analytical methods have limitations; c) quality and completeness of the 
source data cannot be influenced – it may not be possible to adjust for the flaws of individual 
trials at the meta-analytical level. 
Amount and quality of the data 
SILC does not introduce a new therapeutic concept but tends to improve the cosmetic outcome 
of MLC while being at least as practical and safe. Hence, 2411 patients in 30 RCTs should 
generally represent a reasonable basis for its evaluation. Obstacles to this effort are primarily 
due to incomplete reporting and quality of trials. Operating time and incidence of complications 
were the only outcomes addressed in all 30 trials35-64. Also, it is surprising that only 16/30 trials 
provided quantitative data on patient satisfaction with cosmesis. In most of these instances, 
incomplete reporting referred to the failure to explicitly state the lack of events. Next, failure to 
report basic patient characteristics reduced a possibility of exploration of heterogeneity (e.g., 
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impact of sex ratio on the SILC-MLC differences in cosmetic outcome or pain). Finally, failure to 
report measures or to explicitly declare a lack of measures for controlling different biases left a 
high level of uncertainty. Overall, apart from two high-quality trials and one “very low quality” 
trial, the trials were of moderate to low quality considering the standard23 parameters. We find 
three of those to be particularly relevant. If the objective is to evaluate the method per se, 
“mixing” of data from differently skilled surgeons (confounding of skill and method) is 
inappropriate. Therefore, failure to report one’s own level of skill with the investigated method 
is a drawback. A further drawback is a failure to perform patient-blinded evaluation of 
subjective outcomes (pain, cosmesis). Finally, inappropriate handling of patient attrition may 
impact the results particularly in small trials. However, a fairly large number of identified trials 
allowed us to employ analyses that enabled a reasonably unbiased assessment of SILC. 
Main findings 
Operating time and procedure failure 
In all but two trials (Fig. 2A), operating time was longer for SILC than for MLC by at least a few 
minutes. However, considering differences between trials (surgeons’ experience, number of 
SILCs, surgical technique/instruments) the pooled estimate (12.4 minutes) tells little about a 
part that would be “inherent to the method”. The present analysis emphasizes the importance 
of experience/skill with the method. The SILC vs. MLC differences in trials with low risk of 
expertise bias (investigators with ≥10 SILCs before the trial; 9.6 minutes) and those with >40 
SILC-treated patients in the trial (5.9 minutes, p=0.106) suggest that skilled surgeons do not 
require relevantly (if at all) more time to complete SILC than they need for MLC. Since these 
differences were significantly lower (by around 11-12 minutes) than in smaller trials and in trials 
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with a high risk of expertise bias, they could be considered “inherent to SILC”. The present 
analysis indirectly indicates that experience with SILC and operating time (difference vs. MLC) 
are, at least in part, related “through” procedure failure. Procedure failure (almost exclusively a 
need for an additional trocar) was clearly more frequent with SILC but incidence was lower in 
larger trials and in trials with pre-trial SILC-experienced surgeons indicating the “learning 
effect”. The fact that even in trials with >40 SILC-treated patients (3.30%) or with pre-trial 
experienced surgeons (3.60%) incidence of procedure failure with SILC was higher than the 
overall estimate for MLC (0.53%) indicates that there might be some level of procedure failure 
that is “inherent to the method”. 
Intra-operative blood loss 
Present analysis indicates a significantly greater intraoperative blood loss with SILC vs MLC. 
However, the difference (1.29 mL) is small and practically irrelevant. It should be noted also that 
numerical values were in favor of SILC in 5/12 trials, in favor of MLC in 6/12 trials, while one trial 
reported no difference (Fig. 3). Considering the logic of the random-effects meta-analysis 
(estimates the mean of a distribution of individual effects), it seems plausible to conclude that 
the existing number of trials (n=12) is too small to illustrate the true “distribution of effects” – 
one further trial could greatly change the situation. 
Post-operative pain 
Two characteristics were evident regarding post-operative pain: a) use of different 
measurement tools; b) different analgesic strategies in different trials with only sporadically 
precisely defined timing of pain assessment relative to administration of analgesia. The former 
required SMD as a summary effect measure which is not very intuitive in a clinical sense. The 
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latter is an important issue since assessments under analgesia are biased towards a conclusion 
of “no difference”. However, considering the number of trials and patients, it is reasonable to 
consider the pooled estimates as quite robust. The main present finding is that there is no “SILC-
inherent potential” to reduce early postoperative pain (vs. MLC): a) pooled estimate at 24 hours 
post-surgery (adjusted for the number of SILCs, i.e., “surgeons’ skill”) of treatment difference 
when patients were blinded was close to 0 with no effect of trial size; b) when non-blinded 
assessment was performed, SILC yielded significantly less pain (SMD=-0.64, p=0.003), more so in 
trials with more SILC-treated patients. The difference between these two estimates could be 
denoted a “para-SILC effect” or “bias”. Although it might be practically relevant (i.e., if patients 
feel less pain, the “reason” for that is of secondary interest), it apparently depends on surgeons’ 
skill and might not be reproducible.  
Complications 
The present analysis focused on bile- and wound-related complications, but included also “other 
complications” apart from nausea/vomiting and minor non-specific adverse events (identified 
terms listed in Table 6). The problems with the analysis are related to different (across trials) or 
unknown periods of follow-up and failure to explicitly state non-events. These are study-level 
factors and it is difficult or impossible to control for the bias that they could introduce. As an 
example, 19/30 included trials explicitly referred to incisional hernia, 7 reporting at least one 
case, 12 explicitly stating “no events”, but 11 made no reference to this complication. Although 
incisional hernia might not be a complication that would be underreported, it is 
methodologically erroneous to include such trials in the analysis.23 The problem with less 
remarkable (potential) complications is even greater. Consequently, it is not feasible to 
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separately analyze individual complications (apart from the most remarkable ones), rather 
“overall complications” is an outcome of interest. The present analysis indicated no clear SILC 
vs. MLC difference in this respect. Apparently paradoxically, in trials conducted by the pre-trial 
SILC-experienced surgeons, SILC vs. MLC difference was greater (OR=1.56, p=0.096) and 
incidence of complications in the SILC arms was higher (10.7%) than in trials with a 
high/uncertain risk of expertise bias (OR=1.04, p=0.859; SILC pooled incidence 4.0%). Since the 
former trials were characterized by a negligible SILC vs. MLC difference in operating time, 
combined data suggest that SILC inherently is prone to somewhat more local complications 
(biliary, wound-related) than MLC, regardless of the experience with the method, but that this 
could be “leveled-off” by taking more time to complete the procedure. In particular, although 
the total number of events was low (15/839 SILC-treated and 4/837 MLC-treated patients in 19 
trials), the present analysis strongly suggests that SILC is associated with an increased risk of 
incisional hernia (OR=4.94, 95%CI 1.26-19.4, p=0.025). 
Hospital stay 
It has been suggested that SILC could be implemented as a day surgery66, but none of the 
included reports35-64 indicated that the “day surgery” concept was practiced. Under such 
conditions, the present analysis indicates no relevant SILC vs. MLC difference. 
Patient satisfaction with cosmetic outcome 
Considering the almost exclusive use of a 4-port MLC and a variety of small differences in port 
sizes (see Table 3), the existing published RCTs35-64 do not allow for a pooled evaluation of SILC 
separately vs. the 3-port and 4-port MLC (or any of their variations), rather, the only feasible 
comparison is that of SILC vs. “MLC in general”. The use of SMD allowed pooling of data 
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collected with different instruments [most commonly 4 - 11-point Likert scales (sometimes with 
inverse grading), or more complex specific instruments but with different (and even inverse) 
grading] but SMD is not clinically intuitive and this way of “data merging” is not sensitive to 
potential conceptual differences between different instruments. Finally, the overall amount of 
data for the long(er)-term post-surgical periods is still modest - 3 trials (N=390) provided data 
for 6 months and 4 trials (N=351) provided data for 1 year post-surgery. A common problem 
with long(er) trials is patient attrition. For example, the largest trial with 1-year data (Marks 
2013)51 experienced a 20% drop-out rate by this time, and there seems to be no remedy for this 
problem (and the bias that it could introduce) – the “last observation carried-forward” principle, 
that otherwise might help preserve the intent-to-treat analysis, could even further bias the 
results if the natural history of the cosmetic outcome was to show reduced SILC vs. MLC 
difference over time due to improvement in the MLC-treated patients. The amount of data for a 
short(er)-term period (1-3 months) appears reasonable (11 trials, 1232 patients). Numerically, 
all but one trial were in favor of SILC (Fig. 8) and the pooled estimate was highly statistically 
significant. Still, considering the design/conduct differences between trials and heterogeneity of 
treatment effects, it tells little about the effect that would be “inherent to the method”. The 
major finding of the present analysis is that when patients were blinded (6 trials, 719 patients), 
difference in favor or SILC was not statistically significant. At the same time, in a similarly sized 
subset of trials (5 trials, 513 patients) with non-blinded patients, difference in favor of SILC was 
four times greater and statistically significant. The former could be considered a difference 
“inherent to SILC”. Its size, expressed as SMD (0.42) is difficult for clinical interpretation, and it 
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would be so even if expressed in some scale units – unless a minimally important difference had 
been defined. 
Conclusion 
The present systematic review embraced 30 RCTs35-64 comparing SILC to MLC in adult patients 
(N=2411), more than any of the previously published similar reports6-21. Despite the fact that 
the overall trial quality is “far from ideal”, a fairly reasonable evidence-based assessment of SILC 
is possible. Only medium-term (1-3 months post-surgery) data are reasonably numerous 
regarding the main targeted objective of the procedure - a better cosmetic outcome. Although 
technical approach in SILC “promises” improvement over MLC, the present analysis suggests 
that a difference “inherent to SILC” is, at best, modest. In order to adequately assess its clinical 
relevance future trials should use standardized measurement tools and provide long-term data. 
Definition of a “minimally important difference” seems to be necessary. The risk of procedure 
failure, practically exclusively addition of a trocar, is clearly higher with SILC and it inherently 
requires somewhat more time for completion. Both aspects could be minimized with improved 
experience/skill. Since there is no evidence of SILC vs. MLC differences in pain or hospital stay, 
and that the difference in intraoperative blood loss is small and practically irrelevant, it is 
reasonable to state that SILC is acceptable from the (in)convenience standpoint. However, the 
present analysis strongly suggests that the risk of incisional hernia is relevantly higher with SILC. 
Fortunately, absolute numbers are low. Overall, although SILC has been discussed as a potential 
“new standard in cholecystectomcy”54 the presently existing published RCTs comparing it to 
MLC suggest that it should rather be viewed as an acceptable alternative. 
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Fig. 1 Prisma flow-chart of the study selection process.  
* One trial (Marks 2013, see Table 2) was described also in a preliminary report.34 Both papers 
were used to extract methodological particulars, but only the complete report (Marks 2013) was 
used for outcome extraction. 
 
Fig. 2 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in operating time (minutes). A. Random-effects meta-analysis. Data are 
summarized as (weighted) mean differences (WMD), heterogeneity is illustrated by the Q-test 
and I2 value. Inspection of the funnel plot, Egger’s regression and trim-and-fill method did not 
indicate publication bias. The adjudicated levels of differential expertise bias [Diff.exp. (L=low, 
H=high, U=uncertain) are also shown. B. Meta-regression analysis of the SILC vs. MLC WMD with 
two independent variables: risk of expertise bias and number of SILC procedures in the trial. 
Explanation of heterogeneity is indicated by percent between-trial variance explained and 
residual I2. 
 
Fig. 3 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in intraoperative blood loss (mL) - random-effects meta-analysis. Data are 
summarized as (weighted) mean differences (WMD), heterogeneity is illustrated by the Q-test 
and I2 value. Inspection of the funnel plot, Egger’s regression and trim-and-fill method did not 
indicate publication bias. The adjudicated levels of differential expertise bias [Diff.exp. (L=low, 
H=high, U=uncertain) are also shown.  
 
30 
 
Fig. 4 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in incidence of procedure failure. A. Conventional random-effects (Mantel-
Haenszel, M-H) meta-analysis. Data are summarized as odds ratios (OR), heterogeneity is 
illustrated by the Q-test and I2 value. Inspection of the funnel plot, Egger’s regression and trim-
and-fill method did not indicate publication bias. The adjudicated levels of differential expertise 
bias [Diff.exp. (L=low, H=high, U=uncertain) are also shown. B. Pooled estimates (OR) generated 
by methods specifically designed for sparse dichotomous data (no continuity correction, use all 
trials): the bivariate binomial-normal (BN) method30 and method by Shuster29 with unweighted 
(recommended) and weighted estimation. The BN method provides random-effects estimates 
of incidence by treatment and of variance across trials within treatment, and also variance 
across trials between treatments (2) with a formal t-test for heterogeneity (p-values indicated). 
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Fig. 5 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in post-operative pain. A. Pooled random-effects estimates of treatment 
difference (standardized mean difference, SMD) at different times after the surgery (indicated 
time-points, number of trials and patients). Heterogeneity is illustrated by the Q-test and I2 
value. Inspection of the funnel plot, Egger’s regression and trim-and-fill method did not indicate 
publication bias at any point. The largest number of trials reported on 24 hours post-surgery 
(bolded). B. Random-effects meta-analysis at 24 hours post-surgery. The adjudicated levels of 
differential expertise and performance bias [Exp., Perf. (L=low, H=high, U=uncertain)] are also 
shown. C. Meta-regression analysis of the SILC vs. MLC SMD at 24 hours post-surgery with 
independent variables: risk of performance bias, number of SILC procedures in the trial and 
their interaction. Explanation of heterogeneity is indicated by percent between-trial variance 
explained and residual I2. 
 
 
 
 
 
 
 
 
 
 
32 
 
Fig. 6 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in incidence of complications. A. Conventional random-effects (Mantel-
Haenszel, M-H) meta-analysis. Data are summarized as odds ratios (OR), heterogeneity is 
illustrated by the Q-test and I2 value. Inspection of the funnel plot, Egger’s regression and trim-
and-fill method did not indicate publication bias. The adjudicated levels of differential expertise 
and attrition bias [Diff.exp., Attrig. (L=low, H=high, U=uncertain) are also shown. B. Pooled 
estimates (OR) generated by methods specifically designed for sparse dichotomous data (no 
continuity correction, use all trials): the bivariate binomial-normal (BN) method30 and method 
by Shuster29 with unweighted (recommended) and weighted estimation. The BN method 
provides random-effects estimates of incidence by treatment and of variance across trials 
within treatment, and also variance across trials between treatments (2) with a formal t-test for 
heterogeneity (p-values indicated). 
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Fig. 7 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in length of hospital stay (days) - random-effects meta-analysis. Data are 
summarized as (weighted) mean differences (WMD), heterogeneity is illustrated by the Q-test 
and I2 value. Inspection of the funnel plot, Egger’s regression and trim-and-fill method did not 
indicate publication bias. The adjudicated levels of differential expertise, attrition and detection 
bias [Diff.exp., Attrit., Detect., (L=low, H=high, U=uncertain) are also shown.  
 
Fig. 8 Difference between single-incision (SILC) and standard multiport (MLC) laparoscopic 
cholecystectomy in patients’ satisfaction with cosmetic outcome. A. Pooled random-effects 
estimates of treatment difference (standardized mean difference, SMD) at different times after 
the surgery (indicated are time-points, number of trials and patients). Heterogeneity is 
illustrated by the Q-test and I2 value. Inspection of the funnel plot, Egger’s regression and trim-
and-fill method did not indicate publication bias at any point. The largest number of trials 
reported on 1-3 months post-surgery (bolded). B. Random-effects meta-analysis at 1-3 months 
post-surgery. The adjudicated levels of differential expertise, performance and attrition bias 
[Exp., Perf., Attrit. (L=low, H=high, U=uncertain)] are also shown. C. Meta-regression analysis of 
the SILC vs. MLC SMD with the risk of performance bias as an independent variable. Explanation 
of heterogeneity is indicated by percent between-trial variance explained and residual I2. 
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Table 1 Main characteristics of published meta-analyses (by author) of clinical studies comparing single 
incision laparoscopic cholecystectomy and multiport laparoscopic cholecystectomy identified through 
December 9, 2013. 
Author, year  Country  Included studies (N)  Included patients (N) 
Arezzo 2013
6
  Italy  12 RCTs  996 
Bingener 2013
7
  USA  5 RCTs  502 
Garg 2012
8
  India  9 RCTs  659 
Geng 2013
9
  China  25 RCTs (1 pediatric)  1841 
Hao 2012
10
  China  15 RCTs  1113 
Markar 2011
11
  United Kingdom  7 RCTs  375 
Pisanu 2012
12
  Italy  12 RCT  892 
Qiu 2013
13
  China  40 studies, 16 RCTs, 24 non-randomized  3711 
Sajid 2012
14
  United Kingdom  11  858 
Trastulli 2012
15
  Italy  13  923 
Wang, D 2012
16
*  China  9  –  
Wang, Z 2012
17
  China  5  264 
Wu 2012
18
  China  9  755 
Zehetner 2013
19
  USA  9  695 
Zhang 2013
20
  China  11  859 
Zhong 2012
21
  China  7  611 
RCTs, randomized controlled trials 
*Abstract form, number of subjects not declared. 
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Table 2 Main study characteristics (by author). Data presented as in the original publications.35-64 
Study   Country  Patients (N)  Age (years)  Sex ratio F/M  BMI (kg/m2)  Follow-up 
    SILC  MLC  SILC  MLC  SILC  MLC  SILC  MLC   
Aprea 2011*  Italy  25  25  45.5±9.4  44±10  16/14  19/6  25.9±5.8  23.7±4.6  NR 
Bresadola 1999#  Italy  45  45  42±20  45±15  19/9  22/15  NR  NR  NR 
Brown 2013  USA  40  39  42 (21-75)  43 (18-76)  29/11  21/9  27.9±4.3  30.3±6.9  4 weeks 
Bucher 2011  Switzerland  75  75  42 (18-81)  44 (20-78)   NR  NR  26 (22-35)  25 (19-34)  1 month 
Cao 2011  China  57  51  62.2±5.1  59.7±4.4  34/23  29/22  28.6±4.4  29.1±5.1  1 month 
Chang 2012  Singapore  24  26  49.5±11.49  51.2±12.3  14/10  16/10  24.1±4.2  27.7±7.8  2 weeks 
Ellatif 2012  Egypt  125  125  47.7±10.6  46.9±11.4  95/30  88/37  26.9±5.5  29.5±5.6  6 months 
Herrero Fonollosa 2012  Spain  26  24  45±12  49±12  20/6  14/10  26±4  25±2  6 months 
Khorgami 2013I  Iran  30  60  43.8±12.7  41.6±11.1  22/8  41/19  27.9±4.3  27.6±4.2  1 year 
Lai 2011  Hong Kong  24  27  51.7±13.3  54.3±12.0  16/8  16/11  25±3  24.4±2.8  3 months 
Lee 2010  Taiwan  35  35  51.0±13.5  53.3±15.5  22/13  20/15  24.2±3.4  25.8±3.0  6 months 
Leung 2012  USA  36  43  41.8±16.9  52.3±19.8  NR  NR  28.7±6.91  28.4±6.12  Mean: SILC 99, MLC 90 days 
Lirici 2011  Italy  20  20  45 (26-63)  50 (24-67)  14/6  14/6  25 (18-29)  27 (18-30)  1 month 
Luna 2012  Brazil  20  20  NR  NR  NR  NR  NR  NR  30 days 
Ma 2011  USA  21  22  57.3±16  45.8±11.9  NR  NR  28.2±5.3  30.7±6.1  Mean: SILC 19, MLC 16 days 
Madureira 2012  Brazil  28  29  50  56  NR  NR  27.5 (15.6-43.5)  25 (18-34)  5.92 months 
Marks 2013  USA  119  81  45.8 (18-77)  44.0 (19-68)  91/28  57/24  29.0 (15-45)  30.9 (19-45)  1 year 
Mehmood 2010  Pakistan  30  30  44.42±8.59  42.7±9.1  28/2  26/4  NR  NR  NR 
Noguera 201  Spain  20  20  49±4  60±5  17/3  16/4  28±4  30±1  1 year 
Pan 2013  China  49  53  43.8±14  45.2±11  26/23  31/22  24.3±6.0  25.1±5  2 months 
Rašić 2010  Croatia  48  50  44±6  44±5.7  26/22  32/18  27±4  27±4  1 month 
Saad 2012  Germany  35  35  45±17  49±14  7/28  9/26  25.4±2.5  25.4±3.1  1 year 
Sasaki 2012  Japan  27  27  56.6±14.2  58.2±12.3  13/14  13/14  24.4±3.0  24.9±3.4  30 days 
Sinan 2012  Turkey  17  17  48.5±8.9  48.7±14.3  13/4  9/8  27.3±3.1  27.2±2.9  Median: SILC 30, MLC 23 wks 
Solomon 2012  USA  22  11  38.4±3.3  35.5±4.1  22/0  11/0  31.8±1.4  31.4±2.2  30 days 
Tsimoyiannis 2010  Greece  20  20  49.2±16.9  47.9±9.8  15/5  19/1  NR  NR  NR 
Vilallonga 2012  Spain, Turkey  69  71  43.2±14.6  42.6±14.6  38/31  36/35  NR  NR  Mean 7.3 months 
Yilmaz 2013  Turkey  43  40  48.5±12  51.0±9.0  34/9  27/13  24.2±4.0  23.3±3.0  7 days 
Zapf 2013  USA  49  51  44.2±16.2  50.9±18.2  42/7  34/17  29.1±6.5  30.0±6.3  Mean: SILC 16.4, MLC 16.2 m 
Zheng 2011  China  30  30  43.6±11.3  46.8±14.4  17/13  14/16  24.7±3.4  25.9±4.1  Median: SILC 9.4, MLC 11.6 m 
Data are counts, mean±SD, median (range), median±SD in Rašić 2010, mean (range) in Marks 2013 and mean±SE in Noguera 2013. 
BMI, body mass index; SILC, single incision laparoscopic cholecystectomy; MLC, multiport laparoscopic cholecystectomy; NR, not 
reported 
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*Declared number of patients (intent-to-treat) per group was 25, but sex ratio in the SILC group was expressed as 16/14 without any 
explanation. 
#Declared number of patients (intent-to-treat) per group was 45. Patients were excluded due to data incompleteness or procedure 
failure and were not considered regarding demographics. 
IStudy included two MLC groups (3 or 4 ports), each with 30 subjects. Results were practically identical, hence groups were pooled. 
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Table 3 Surgical technique/instruments used (studies by author) as presented in the original publications.35-64 
Author  Trocars in MLC   Trocars/ports in SILC   Instruments in SILC 
Aprea 2011  3, 2x12-mm + 1x5-mm  TriPort LAD (Olympus); 2x5-mm + 1x12-mm  Conventional 
Bresadola 1999  4,diameters not specified  1x10-mm + 1x5-mm, single supraumbilical skin incision  Conventional or roticulator 
Brown 2013  4, 1x11-mm + 3x5-mm  1x10-mm + 2x5-mm through the same skin incision  Conventional 
Bucher 2011  4, 2x10-mm + 2x5-mm  TriPort® (Advanced Surgical Concepts, Wicklow, Ireland)  Flexible 
Cao 2011  3, 2x10-mm + 1x5-mm  1x10-mm + 2x5-mm, single umbilical skin incision  Conventional 
Chang 2012  4, 1x10-mm + 3x5-mm  The Covidien (Norwalk, USA) SILS port  Articulating 
Ellatif 2012  4, 2x10-mm + 2x5-mm  1x10-mm + 1x5-mm transumbilical ports  Conventional 
Herrero Fonollosa 2012  4, 2x10-mm + 2x5-mm  SILS port, Covidien  Articulating 
Khorgami 2013  3 or 4, 1x10-mm + 2 or 3x5 mm  1x10-mm + 2x5-mm through the same skin incision  Conventional 
Lai 2011  4, 1x10-mm + 3x5-mm  SILS Port (Covidien Inc., Norwalk, CT)  Conventional 
Lee 2010  4, 1x10-mm + 3x3-mm  QuadraPort® LAD (LAGIS, Taiwan); 1x10-mm, 2x5-mm + 1x3-mm   Conventional 
Leung 2012  NR  NR  Articulating 
Lirici 2011  4, 2x12-mm + 2x5-mm  TriPort® (Olympus America, Center Valley, PA); 1x12-mm + 2x5-mm   Conventional 
Luna 2012  4, 2x10-mm 2x5-mm  SITRACC® device (EDLO, Rio Grandedo Sul, Brazil); 1x10-mm + 3x5-mm  Conventional and angulated 
Ma 2011  4, 1x10-mm + 3x5-mm  ASC TriPort (Advanced Surgical Concepts, Wicklow, Ireland)  Articulating 
Madureira 2012  4, 10-mm and 5-mm ports (n=?)  SITRACC® portal (Edlo S.A., Curitiba, Brazil), SILS
TM
 Port (Covidien, 
Mansfield, MA); X-cone® (Karl Storz Endoskope, Tuttlingen, Germany) 
 Curved and conventional 
Marks 2013  3 or 4, 2 or 3x5-mm, 1 or 2x10/12-mm  SILS™ Port (Covidien)  Conventional and roticulating 
Mehmood 2010  4, 2x10-mm + 2x5-mm  SILS
TM
 port  Conventional or articulating 
Noguera 2013  3, 1x11-mm + 2x5-mm  SILS™ Port (Covidien)  Conventional and articulating 
Pan 2013  3, 2x10-mm + 1x5-mm  2x10-mm (Kanger, Tong Lu, China); intraumbilical incision  Conventional 
Rašić 2010  3, port size not specified  1x10-mm + 2x5-mm through the same skin incision  Roticulator 
Saad 2012  4, 2x10-mm + 2x5-mm  SILS Port® (Covidien, Norwalk, CT, USA); 3x5 or 1x10 + 2x5-mm  Conventional 
Sasaki 2012  4, 1x12-mm + 3x5-mm  SILS port (Covidien, New Haven, CT)  Roticulating and conventional 
Sinan 2012  4, 2x5-mm + 2x10-mm  Single port designed for SILC (Covidien, New Haven, CT)  Roticulating 
Solomon 2012  4, 1x11-mm + 3x5-mm  SILS™ Port (Covidien)  Roticulating and conventional 
Tsimoyiannis 2010  4, 1x11-mm 3x5-mm  1x10-mm + 2x5-mm through the same skin incision  Conventional and roticulating 
Vilallonga 2012  3 or 4, 1xJason + 1x11-mm + 1 or 2x5-
mm 
 TriPort™ (Advanced Surgical Concepts, Wicklow, Ireland) and SILS™ 
Port (Covidien, Inc., Norwalk, CT) 
 Conventional and roticulating 
Yilmaz 2013  4, 1x10-mm + 3x11-mm  SILS™ Port (Covidien)  Not reported 
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Zapf 2013  4, 1x12-mm + 3x5-mm  3 low-profile ports through the same skin incision  Articulating 
Zheng 2011  3, 2x10-mm + 1x5-mm  Tri-port (Advanced Surgical Concepts, Wicklow, Ireland)  Conventional 
MLC, multiport laparoscopic cholecystectomy; SILC, single incision laparoscopic cholecystectomy; LAD, laparoscopic Access Device 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
Table 4 Risk of bias: summary of included trials (by author).35-64 
Study  Random sequence 
generation 
(selection bias) 
 Allocation 
concealment 
(selection bias) 
 Blinding of 
participants 
(performance bias) 
 Blinding of 
assessors 
(detection bias) 
 Incomplete 
outcome data 
(attrition bias) 
 Selective 
reporting 
(reporting bias) 
 Differential 
expertise bias 
(other biases) 
Aprea 2011  ?  +  –  ?  +  +  – 
Bresadola 1999  ?  ?  ?  +  –  –  – 
Brown 2013  ?  ?  +  ?  +  –  ? 
Bucher 2011  +  ?  ?  +  +  +  + 
Cao 2011  ?  +  ?  +  –  +  – 
Chang 2012  ?  ?  +  +  +  +  – 
Ellatif 2012  +  +  +  +  +  +  + 
Herrero Fonollosa 2012  +  ?  ?  ?  ?  –  ? 
Khorgami 2013  +  ?  +  +  ?  +  ? 
Lai 2011  +  +  –  +  –  +  + 
Lee 2010  ?  +  ?  +  +  +  + 
Leung 2012  +  ?  +  ?  ?  –  + 
Lirici 2011  ?  +  +  +  +  +  – 
Luna 2012  ?  ?  ?  ?  +  +  – 
Ma 2011  +  ?  ?  +  ?  +  – 
Madureira 2012  ?  ?  ?  ?  –  +  + 
Marks 2013  +  +  +  ?  ?  +  + 
Mehmood 2010  ?  +  ?  ?  ?  +  – 
Noguera 2013  +  ?  ?  ?  +  +  ? 
Pan 2013  +  +  ?  ?  –  +  ? 
Rašić 2010  +  ?  ?  ?  +  –  ? 
Saad 2012  +  +  +  +  +  +  + 
Sasaki 2012  +  ?  ?  ?  +  +  ? 
Sinan 2012  +  ?  ?  +  +  +  ? 
Solomon 2012  ?  ?  ?  ?  +  –  + 
Tsimoyiannis 2010  ?  +  ?  +  ?  +  – 
Vilallonga 2012  ?  ?  ?  ?  ?  +  – 
Yilmaz 2013  +  +  ?  ?  -  +  ? 
Zapf 2013  +  ?  +  +  +  +  - 
Zheng 2011  +  +  ?  ?  +  +  + 
+, low risk of bias; –, high risk of bias; ?, unclear risk of bias 
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Table 5 Ranking of trials35-64 (highest to lowest quality) based on a combination of evidently low (primary criterion) or evidently high 
(secondary criterion) or uncertain risks (tertiary criterion) of the seven biases assessed in Table 4. Except for the definition of high-
quality trials (all risks evidently low), categorization/ranking by quality is arbitrary and serves only as an illustrative summary. 
Study  Size  Rank  Quality  Description  Evidently low risks   Evidently high risks  Uncertain risks 
Ellatif 2012  250  1  High  All risks evidently low  7  0  0 
Saad 2012  70  1  High   7  0  0 
Bucher 2011  150  2  Moderate   
 
Evidently low risks clearly 
prevail over evidently high 
risks, uncertainty low 
 5  0  2 
Lee 2010  70  2  Moderate   5  0  2 
Marks 2013  200  2  Moderate   5  0  2 
Zheng 2011  60  2  Moderate   5  0  2 
Lirici 2011  40  3  Moderate   5  1  1 
Zapf 2013  100  3  Moderate   5  1  1 
Lai 2011  51  4  Moderate   5  2  0 
Khorgami 2013  90  5  Modest    4  0  3 
Sinan 2012  34  5  Modest   
Evidently low risks clearly 
prevail over evidently high 
risks, uncertainty high 
 4  0  3 
Chang 2012  50  6  Modest   4  1  2 
Noguera 2013  40  7  Modest   3  0  4 
Sasaki 2012  54  7  Modest   3  0  4 
Leung 2012  79  8  Modest   3  1  3 
Tsimoyiannis 2010  40  8  Modest   3  1  3 
Yilmaz 2013  83  8  Modest   3  1  3 
Aprea 2011  50  9  Low   
 
Evidently low risks barely 
prevail or are equally frequent 
as evidently high risks, 
uncertainty high 
 3  2  2 
Cao 2011  108  9  Low   3  2  2 
Brown 2013  79  10  Low   2  1  4 
Luna 2012  40  10  Low   2  1  4 
Ma 2011  43  10  Low   2  1  4 
Madureira 2012  57  10  Low   2  1  4 
Mehmood 2010  60  10  Low   2  1  4 
Pan 2013  102  10  Low   2  1  4 
Rašić 2010  98  10  Low   2  1  4 
Solomon 2012  33  10  Low   2  1  4 
Herrero Fonollosa 2012  50  11  Low   1  1  5 
Vilallonga 2012  140  11  Low   1  1  5 
Bresadola 1999  90  12  Very low  Evidently high risks prevail  1  3  3 
* see footnote to Table 4 
8 
 
Table 6 Cumulative number of patients by type of reported complications in randomized 
controlled trials (N=30) comparing single incision laparoscopic cholecystectomy (SILC) and 
multiport laparoscopic cholecystectomy (MLC). Complications are listed by preferred terms 
used in the original reports.35-64 
Complication type  SILC   MLC  
Biliary complications     
Gallbladder perforation  11  12 
Bile leakage  9  9 
Retained bile duct stone  4  1 
Bleeding in gallbladder bed  1  2 
Biliary peritonitis  1  0 
Cystic duct partial avulsion  0  1 
Wound complications     
Contusion/hematoma/seroma  20  21 
Infection  17  19 
Incisional hernia  15  4 
Erythema  5  0 
Bleeding  1  3 
Cellulitis  2  0 
Other     
Urinary retention  1  2 
Suture-related complication  2  0 
Subphrenic abscess  2  0 
Blood collection  2  0 
Perforation of diaphragm  1  0 
Liver dysfunction  0  1 
Postoperative ileus  0  1 
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Table 7 Random-effects meta-analysis of the outcome “incidence of incisional hernia”.*  
  SILC  MLC  Effect 
Study   n  N  n  N  OR  95% CI 
Bucher 2011  0  75  0  75  1.00  NE 
Ellatif 2012  0  125  0  125  1.00  NE 
Herrero Fonollosa 2012  0  26  0  24  0.93  NE 
Khorgami 2013  0  30  1  60  0.65  NE – 78.0 
Leung 2012  0  36  0  43  1.19  NE 
Lirici 2011  0  20  0  20  1.00  NE 
Luna 2012  0  20  0  20  1.00  NE 
Ma 2011  1  21  0  22  3.29  0.03 - NE 
Madureira 2012  0  28  0  29  1.04  NE 
Marks 2013  10  119  1  81  7.34  0.92 – 58.5 
Noguera 2013  0  20  0  20  1.00  NE 
Pan 2013  0  49  0  53  1.80  NE 
Rašić 2010  0  48  0  50  1.00  NE 
Saad 2012  1  35  0  35  3.09  0.03 - NE 
Sinan 2012  1  17  0  17  3.18  0.03 - NE 
Solomon 2012  1  22  0  11  1.61  0.01 - NE 
Vilallonga 2012  1  69  2  71  0.61  0.01 – 10.0 
Zapf 2013  0  49  0  51  1.04  NE 
Zheng 2011  0  30  0  30  1.00  NE 
Conventional (trials used= 7) 
 
15 / 313 
 
4 / 297 
    
OR (95% CI), p-value  2.17 (0.75-6.33), 0.155    
Methods for sparse data (trials used= 19) 
 
15 / 839 
 
4 / 837 
    
BN method OR (95% CI), p-value  3.19 (0.87-11.72), 0.077    
Shuster weighted OR (95% CI), p-value  3.37 (0.94-12.10), p=0.063 
   
Shuster unweighted OR (95%CI), p-value  4.94 (1.26-19.4), 0.025 
   
NE – not estimable 
*We followed the recommended procedure29: a) in trials with one or both zero-event arms, 
individual study odds ratio (OR) estimates are conditional exact, the remaining are conventional 
Mantel-Haenszel random-effects estimates (no continuity correction used in estimation); b) 
pooled effects are by the bivariate binomial-normal (BN) method30, or by the study-size 
weighted or unweighted (preferred, bolded) method by Shuster29. 
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